These data should be extrapolated with caution to human cerebrovascular disease but suggest that kinins can afford brain protection against ischemia through B1R activation when produced locally but if released in the circulation aggravate the condition, through peripheral B2R activation. The gene discussed is BDKRB2; the disease is ischemia.